CIBC Asset Management
RYTM icon

CIBC Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

CIBC Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$248K Hold
2,848
– – ﹤0.01% 1094
2025
Q4 		$305K Buy
+2,848
New +$302K ﹤0.01% 964

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

CIBC Asset Management's RYTM Position: Q1 2026 in Review

CIBC Asset Management held its Rhythm Pharmaceuticals (RYTM) position steady in Q1 2026 at 2,848 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #1094.

CIBC Asset Management first reported a position in RYTM in Q4 2025 and has held it in 2 quarters since. The position peaked at $305K in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • CIBC Asset Management held 2,848 shares of Rhythm Pharmaceuticals worth $248K as of Q1 2026.
  • CIBC Asset Management left its Rhythm Pharmaceuticals share count unchanged in Q1 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of CIBC Asset Management's portfolio in Q1 2026, its #1094 holding.
  • CIBC Asset Management first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • CIBC Asset Management's Rhythm Pharmaceuticals position peaked at $305K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on CIBC Asset Management's 13F filing for Q1 2026, filed 12 May 2026.